BEUDAMED
    11 results · 6ms · Sources: EU EUDAMED, US FDA

    Get notified when this changes

    We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.
    Filters FDA Classification × Classification: FDA Class 2 × Clear all

    Catheters, Salpingography

    FDA classification
    FDA Class 2 ·Catheters, Salpingography

    Prosthesis, Knee, Patello/Femorotibial, Semi-Constrained, Uhmwpe, Pegged, Cemented, Polymer/Metal/Polymer

    FDA classification
    FDA Class 2 ·Prosthesis, Knee, Patello/Femorotibial, Semi-Constrained, Uhmwpe, Pegged, Cemented, Polymer/Metal/Polymer

    Syringe, Balloon Inflation

    FDA classification
    FDA Class 2 ·Syringe, Balloon Inflation

    Sars-Cov-2 Serology Test

    FDA classification
    FDA Class 2 ·Sars-Cov-2 Serology Test

    Respiratory Specimen Nucleic Acid Sars-Cov-2 Test

    FDA classification
    FDA Class 2 ·Respiratory Specimen Nucleic Acid Sars-Cov-2 Test

    Mers-Cov And Common Respiratory Pathogens Multiplex Nucleic Acid Detection System

    FDA classification
    FDA Class 2 ·Mers-Cov And Common Respiratory Pathogens Multiplex Nucleic Acid Detection System

    Over-The-Counter Molecular Test To Detect Sars-Cov-2 From Clinical Specimens

    FDA classification
    FDA Class 2 ·Over-The-Counter Molecular Test To Detect Sars-Cov-2 From Clinical Specimens

    Mers-Cov And Common Respiratory Pathogens Semi-Quantitative And Quantitative Multiplex Nucleic Acid Detection System

    FDA classification
    FDA Class 2 ·Mers-Cov And Common Respiratory Pathogens Semi-Quantitative And Quantitative Multiplex Nucleic Acid Detection System

    Multi-Target Respiratory Specimen Nucleic Acid Test Including Sars-Cov-2 And Other Microbial Agents

    FDA classification
    FDA Class 2 ·Multi-Target Respiratory Specimen Nucleic Acid Test Including Sars-Cov-2 And Other Microbial Agents

    Simple Point-Of-Care Device To Directly Detect Sars-Cov-2 Viral Targets From Clinical Specimens In Near-Patient Settings

    FDA classification
    FDA Class 2 ·Simple Point-Of-Care Device To Directly Detect Sars-Cov-2 Viral Targets From Clinical Specimens In Near-Patient Settings

    Simple Point-Of-Care Device To Detect Sar-Cov-2 Nucleic Acid Targets From Clinical Specimens In Near-Patient Settings

    FDA classification
    FDA Class 2 ·Simple Point-Of-Care Device To Detect Sar-Cov-2 Nucleic Acid Targets From Clinical Specimens In Near-Patient Settings